Recent findings in non-small cell lung cancer (NSCLC) patients demonstrated a higher proportion of CX3CR1+ CD8+ T cells in peripheral blood compared to tumor tissue. This evidence concerns the gene CX3CR1 and non-small cell lung carcinoma.